Publication Cover
Immunological Investigations
A Journal of Molecular and Cellular Immunology
Volume 52, 2023 - Issue 7
691
Views
0
CrossRef citations to date
0
Altmetric
Review Article

Circulating and Synovial Monocytes in Arthritis and Ex-Vivo Model to Evaluate Therapeutic Modulation of Synovial Monocytes

, ORCID Icon, ORCID Icon, , & ORCID Icon

References

  • Abji, F., Rasti, M., Gomez-Aristizabal, A., Muytjens, C., Saifeddine, M., Mihara, K., Motahhari, M., Gandhi, R., Viswanathan, S., Hollenberg, M. D., Oikonomopoulou, K., & Chandran, V. (2020). Proteinase-mediated macrophage signaling in psoriatic arthritis. Frontiers in Immunology, 11, 629726. https://doi.org/10.3389/fimmu.2020.629726
  • Adamopoulos, I. E., Sabokbar, A., Wordsworth, B. P., Carr, A., Ferguson, D. J., & Athanasou, N. A. (2006, January). Synovial fluid macrophages are capable of osteoclast formation and resorption. The Journal of Pathology, 208(1), 35–43. https://doi.org/10.1002/path.1891
  • Alivernini, S., MacDonald, L., Elmesmari, A., Finlay, S., Tolusso, B., Gigante, M. R., Petricca, L., DiMario, C., Bui, L., Perniola, S., Attar, M., Gessi, M., Fedele, A. L., Chilaka, S., Somma, D., Sansom, S. N., Filer, A., McSharry, C., Millar, N. L., ... Kurowska-Stolarska, M. (2020, August). Distinct synovial tissue macrophage subsets regulate inflammation and remission in rheumatoid arthritis. Nature Medicine, 26(8), 1295–1306. https://doi.org/10.1038/s41591-020-0939-8
  • Ancuta, P., Liu, K. Y., Misra, V., Wacleche, V., Gosselin, A., Zhou, X., & Gabuzda, D. (2009, August 27). Transcriptional profiling reveals developmental relationship and distinct biological functions of CD16+ and CD16- monocyte subsets. BMC Genomics, 10, 403. https://doi.org/10.1186/1471-2164-10-403
  • Ayhan, E., Kesmezacar, H., & Akgun, I. (2014, July). Intraarticular injections (corticosteroid, hyaluronic acid, platelet rich plasma) for the knee osteoarthritis. World Journal of Orthopedics, 5(3), 351–361. https://doi.org/10.5312/wjo.v5.i3.351
  • Barczyk, K., Ehrchen, J., Tenbrock, K., Ahlmann, M., Kneidl, J., Viemann, D., & Roth, J. (2010, July). Glucocorticoids promote survival of anti-inflammatory macrophages via stimulation of adenosine receptor A3. Blood, 116(3), 446–455. https://doi.org/10.1182/blood-2009-10-247106
  • Barnes, P. J. (2017). Glucocorticosteroids. Handbook of Experimental Pharmacology, 237, 93–115. https://doi.org/10.1007/164_2016_62
  • Batko, B., Schramm-Luc, A., Skiba, D. S., Mikolajczyk, T., & Siedlinski, M. (2019, January). TNF-α inhibitors decrease classical CD14(hi)CD16− Monocyte subsets in highly active, conventional treatment refractory rheumatoid arthritis and ankylosing spondylitis. International Journal of Molecular Sciences, 20(2), 291. https://doi.org/10.3390/ijms20020291
  • Belge, K. U., Dayyani, F., Horelt, A., Siedlar, M., Frankenberger, M., Frankenberger, B., Espevik, T., & Ziegler-Heitbrock, L. (2002, April). The proinflammatory CD14+CD16+DR++ monocytes are a major source of TNF. Journal of Immunology, 168(7), 3536–3542. https://doi.org/10.4049/jimmunol.168.7.3536
  • Bellamy, N., Campbell, J., Robinson, V., Welch, V., Gee, T. L., Bourne, R., & Wells, G. A. (2005, April). Intraarticular corticosteroid for treatment of osteoarthritis of the knee. Cochrane Database of Systematic Reviews, 18(2), CD005328.
  • Benham, H., Norris, P., Goodall, J., Wechalekar, M. D., FitzGerald, O., Szentpetery, A., Smith, M., Thomas, R., & Gaston, H. (2013, September). Th17 and Th22 cells in psoriatic arthritis and psoriasis. Arthritis Research & Therapy, 15(5), R136. https://doi.org/10.1186/ar4317
  • Benito, M. J., Veale, D. J., & FitzGerald, O., Van Den Berg, W. B., & Bresnihan, B. (2005, September). Synovial tissue inflammation in early and late osteoarthritis. Annals of the Rheumatic Diseases, 64 (9), 1263–1267. https://doi.org/10.1136/ard.2004.025270
  • Blyth, T., Hunter, J. A., & Stirling, A. (1994, May). Pain relief in the rheumatoid knee after steroid injection. A single-blind comparison of hydrocortisone succinate, and triamcinolone acetonide or hexacetonide. British Journal of Rheumatology, 33(5), 461–463. https://doi.org/10.1093/rheumatology/33.5.461
  • Bonelli, M., Ferner, E., Goschl, L., Blüml, S., Hladik, A., Karonitsch, T., Kiener, H. P., Byrne, R., Niederreiter, B., Steiner, C. W., Rath, E., Bergmann, M., Smolen, J. S., & Scheinecker, C. (2013, March). Abatacept (CTLA-4IG) treatment reduces the migratory capacity of monocytes in patients with rheumatoid arthritis. Arthritis & Rheumatism, 65(3), 599–607. https://doi.org/10.1002/art.37787
  • Boyette, L. B., Macedo, C., Hadi, K., Elinoff, B. D., Walters, J. T., Ramaswami, B., Chalasani, G., Taboas, J. M., Lakkis, F. G., & Metes, D. M. (2017). Phenotype, function, and differentiation potential of human monocyte subsets. PLoS One, 12(4), e0176460. https://doi.org/10.1371/journal.pone.0176460
  • Burbano, C., Rojas, M., Munoz-Vahos, C., Vanegas-García, A., Correa, L. A., Vásquez, G., & Castaño, D. (2018, December). Extracellular vesicles are associated with the systemic inflammation of patients with seropositive rheumatoid arthritis. Scientific Reports, 8(1), 17917. https://doi.org/10.1038/s41598-018-36335-x
  • Cain, D. W., & Cidlowski, J. A. (2017, April). Immune regulation by glucocorticoids. Nature Reviews: Immunology, 17(4), 233–247. https://doi.org/10.1038/nri.2017.1
  • Cambridge, G., Stohl, W., Leandro, M. J., Migone, T.-S., Hilbert, D. M., & Edwards, J. C. W. (2006, March). Circulating levels of B lymphocyte stimulator in patients with rheumatoid arthritis following rituximab treatment: Relationships with B cell depletion, circulating antibodies, and clinical relapse. Arthritis & Rheumatism, 54(3), 723–732. https://doi.org/10.1002/art.21650
  • Catrina, A. I., Trollmo, C., Af Klint, E., Engstrom, M., Lampa, J., Hermansson, Y., Klareskog, L., & Ulfgren, A. K. (2005, January). Evidence that anti-tumor necrosis factor therapy with both etanercept and infliximab induces apoptosis in macrophages, but not lymphocytes, in rheumatoid arthritis joints: Extended report. Arthritis & Rheumatism, 52(1), 61–72. https://doi.org/10.1002/art.20764
  • Chabaud, M., Lubberts, E., Joosten, L., van den Berg, W., & Miossec, P. (2001). IL-17 derived from juxta-articular bone and synovium contributes to joint degradation in rheumatoid arthritis. Arthritis Research, 3(3), 168–177. https://doi.org/10.1186/ar294
  • Chao, R., & Kavanaugh, A. (2019, December). Psoriatic arthritis: Newer and older therapies. Current Rheumatology Reports, 21(12), 75. https://doi.org/10.1007/s11926-019-0866-1
  • Chara, L., Sanchez-Atrio, A., Perez, A., Cuende, E., Albarrán, F., Turrión, A., Chevarria, J., Del Barco, A. A., Sánchez, M. A., Monserrat, J., Prieto, A., de la Hera, A., Sanz, I., Diaz, D., & Alvarez-Mon, M. (2015, January 16). The number of circulating monocytes as biomarkers of the clinical response to methotrexate in untreated patients with rheumatoid arthritis. Journal of Translational Medicine, 13, 2. https://doi.org/10.1186/s12967-014-0375-y
  • Chara, L., Sanchez-Atrio, A., Perez, A., Cuende, E., Albarrán, F., Turrión, A., Chevarria, J., Sánchez, M. A., Monserrat, J., de la Hera, A., Prieto, A., Sanz, I., Diaz, D., & Alvarez-Mon, M. (2012, July). Monocyte populations as markers of response to adalimumab plus MTX in rheumatoid arthritis. Arthritis Research & Therapy, 14(4), R175. https://doi.org/10.1186/ar3928
  • Chatzidionysiou, K., Circiumaru, A., Rethi, B., Joshua, V., Engstrom, M., Hensvold, A., Af Klint, E., & Catrina, A. (2021, June). Tocilizumab decreases T cells but not macrophages in the synovium of patients with rheumatoid arthritis while it increases the levels of serum interleukin-6 and RANKL. RMD Open, 7(2), e001662. https://doi.org/10.1136/rmdopen-2021-001662
  • Chen, Y., Yuan, J., Cai, Z., & Ma, Y. (2023, July). Efficacy of tumor necrosis factor inhibitor combined with intra-articular injection of triamcinolone acetonide in the treatment of refractory rheumatoid arthritis synovitis: A retrospective study. Clinical Rheumatology, 42(7), 1793–1799. https://doi.org/10.1007/s10067-023-06530-x
  • Chiu, Y. G., Shao, T., Feng, C., Mensah, K. A., Thullen, M., Schwarz, E. M., & Ritchlin, C. T. (2010). CD16 (FcRγiii) as a potential marker of osteoclast precursors in psoriatic arthritis. Arthritis Research & Therapy, 12(1), R14. https://doi.org/10.1186/ar2915
  • Cren, M., Nziza, N., Carbasse, A., Mahe, P., Dufourcq-Lopez, E., Delpont, M., Chevassus, H., Khalil, M., Mura, T., Duroux-Richard, I., Apparailly, F., Jeziorski, E., & Louis-Plence, P. (2020). Differential accumulation and activation of monocyte and dendritic cell subsets in inflamed synovial fluid discriminates between Juvenile idiopathic arthritis and septic arthritis. Frontiers in Immunology, 11, 1716. https://doi.org/10.3389/fimmu.2020.01716
  • Cutolo, M., Bisso, A., Sulli, A., Felli, L., Briata, M., Pizzorni, C., & Villaggio, B. (2000, November). Antiproliferative and antiinflammatory effects of methotrexate on cultured differentiating myeloid monocytic cells (THP-1) but not on synovial macrophages from patients with rheumatoid arthritis. The Journal of Rheumatology, 27(11), 2551–2557.
  • Cutolo, M., Capellino, S., Montagna, P., Sulli, A., Seriolo, B., & Villaggio, B. (2006, June). Anti-inflammatory effects of leflunomide in combination with methotrexate on co-culture of T lymphocytes and synovial macrophages from rheumatoid arthritis patients. Annals of the Rheumatic Diseases, 65 (6), 728–735. https://doi.org/10.1136/ard.2005.045641
  • Cutolo, M., Soldano, S., Gotelli, E., Montagna, P., Campitiello, R., Paolino, S., Pizzorni, C., Sulli, A., Smith, V., & Tardito, S. (2021, December). CTLA4-Ig treatment induces M1–M2 shift in cultured monocyte-derived macrophages from healthy subjects and rheumatoid arthritis patients. Arthritis Research & Therapy, 23(1), 306. https://doi.org/10.1186/s13075-021-02691-9
  • Cutolo, M., Sulli, A., Ghiorzo, P., Pizzorni, C., Craviotto, C., & Villaggio, B. (2003, April). Anti-inflammatory effects of leflunomide on cultured synovial macrophages from patients with rheumatoid arthritis. Annals of the Rheumatic Diseases, 62 (4), 297–302. https://doi.org/10.1136/ard.62.4.297
  • Davignon, J. L., Hayder, M., Baron, M., Boyer, J.-F., Constantin, A., Apparailly, F., Poupot, R., & Cantagrel, A. (2013, April). Targeting monocytes/macrophages in the treatment of rheumatoid arthritis. Rheumatology (Oxford), 52(4), 590–598. https://doi.org/10.1093/rheumatology/kes304
  • Dayer, J. M., & Choy, E. (2010, January). Therapeutic targets in rheumatoid arthritis: The interleukin-6 receptor. Rheumatology (Oxford), 49(1), 15–24. https://doi.org/10.1093/rheumatology/kep329
  • Deora, A., Hegde, S., Lee, J., Choi, C.-H., Chang, Q., Lee, C., Eaton, L., Tang, H., Wang, D., Lee, D., Michalak, M., Tomlinson, M., Tao, Q., Gaur, N., Harvey, B., McLoughlin, S., Labkovsky, B., & Ghayur, T. (2017, May/June). Transmembrane TNF-dependent uptake of anti-TNF antibodies. Mabs, 9(4), 680–695. https://doi.org/10.1080/19420862.2017.1304869
  • Diallo, K., Simons, N., Sayegh, S., Baron, M., Degboé, Y., Boyer, J.-F., Kruglov, A., Nedospasov, S., Novarino, J., Aloulou, M., Fazilleau, N., Constantin, A., Cantagrel, A., Davignon, J.-L., & Rauwel, B. (2021, April). Evidence for tmTNF reverse signaling in vivo: Implications for an arginase-1-mediated therapeutic effect of TNF inhibitors during inflammation. iScience, 24(4), 102331. https://doi.org/10.1016/j.isci.2021.102331
  • Durand, M., Komarova, S. V., Bhargava, A., Trebec-Reynolds, D. P., Li, K., Fiorino, C., Maria, O., Nabavi, N., Manolson, M. F., Harrison, R. E., Dixon, S. J., Sims, S. M., Mizianty, M. J., Kurgan, L., Haroun, S., Boire, G., Lucena-Fernandes, M. D. F., & de Brum-Fernandes, A. J. (2013, January). Monocytes from patients with osteoarthritis display increased osteoclastogenesis and bone resorption: The in vitro Osteoclast Differentiation in Arthritis study. Arthritis & Rheumatism, 65(1), 148–158. https://doi.org/10.1002/art.37722
  • Eder, L., Chandran, V., Ueng, J., Bhella, S., Lee, K.-A., Rahman, P., Pope, A., Cook, R. J., & Gladman, D. D. (2010, July). Predictors of response to intra-articular steroid injection in psoriatic arthritis. Rheumatology (Oxford), 49(7), 1367–1373. https://doi.org/10.1093/rheumatology/keq102
  • Ferrao Blanco, M. N., Bastiaansen Jenniskens, Y. M., Kops, N., Chavli, A., Narcisi, R., Botter, S. M., Leenen, P. J. M., Osch, G. J. V. M., & Fahy, N. (2022, June). Intra-articular injection of triamcinolone acetonide sustains macrophage levels and aggravates osteophytosis during degenerative joint disease in mice. British Journal of Pharmacology, 179(11), 2771–2784. https://doi.org/10.1111/bph.15780
  • Fiechter, R. H., de Jong, H. M., van Mens, L. J. J., Fluri, I. A., Tas, S. W., Baeten, D. L. P., Yeremenko, N. G., & van de Sande, M. G. H. (2021). IL-12p40/IL-23p40 blockade with ustekinumab decreases the synovial inflammatory infiltrate through modulation of multiple signaling pathways including MAPK-ERK and Wnt. Frontiers in Immunology, 12, 611656. https://doi.org/10.3389/fimmu.2021.611656
  • Firestein, G. S. (2003, May). Evolving concepts of rheumatoid arthritis. Nature, 423(6937), 356–361. https://doi.org/10.1038/nature01661
  • Fragoulis, G. E., McInnes, I. B., & Siebert, S. (2019, February). JAK-inhibitors. New players in the field of immune-mediated diseases, beyond rheumatoid arthritis. Rheumatology (Oxford), 58(Suppl 1), i43–i54. https://doi.org/10.1093/rheumatology/key276
  • Fukue, R., Okazaki, Y., Gono, T., & Kuwana, M. (2022, August). Abatacept downregulates Fcγ receptor I on circulating monocytes: A potential therapeutic mechanism in patients with rheumatoid arthritis. Arthritis Research & Therapy, 24(1), 194. https://doi.org/10.1186/s13075-022-02886-8
  • Gertel, S., Polachek, A., Furer, V., Paran, D., Tzemach, R., Levartovsky, D., Litinsky, I., Anouk, M., Meridor, K., Nochomovitz, H., Wollman, J., Berman, M., Borok, S., & Elkayam, O. (2023, March 2). Synovial monocytes from psoriatic and rheumatoid arthritis patients are modulated differently by TNF inhibitors and glucocorticoids: An ex-vivo study. Clinical and Experimental Rheumatology. https://doi.org/10.55563/clinexprheumatol/d3mfat
  • Gomez-Aristizabal, A., Gandhi, R., Mahomed, N. N., Marshall, K. W., & Viswanathan, S. (2019, January). Synovial fluid monocyte/macrophage subsets and their correlation to patient-reported outcomes in osteoarthritic patients: A cohort study. Arthritis Research & Therapy, 21(1), 26. https://doi.org/10.1186/s13075-018-1798-2
  • Greven, D. E., Cohen, E. S., Gerlag, D. M., Campbell, J., Woods, J., Davis, N., van Nieuwenhuijze, A., Lewis, A., Heasmen, S., McCourt, M., Corkill, D., Dodd, A., Elvin, J., Statache, G., Wicks, I. P., Anderson, I. K., Nash, A., Sleeman, M. A., & Tak, P. P. (2015, October). Preclinical characterisation of the GM-CSF receptor as a therapeutic target in rheumatoid arthritis. Annals of the Rheumatic Diseases, 74(10), 1924–1930. https://doi.org/10.1136/annrheumdis-2014-205234
  • Guilliams, M., Mildner, A., & Yona, S. (2018, October). Developmental and functional heterogeneity of monocytes. Immunity, 49(4), 595–613. https://doi.org/10.1016/j.immuni.2018.10.005
  • Hajialilo, M., Ghorbanihaghjo, A., Valaee, L., Kolahi, S., Rashtchizadeh, N., Amirkhiz, M. B., Malekmahdavi, I., & Khabbazi, A. (2016, December). A double-blind randomized comparative study of triamcinolone hexacetonide and dexamethasone intra-articular injection for the treatment of knee joint arthritis in rheumatoid arthritis. Clinical Rheumatology, 35(12), 2887–2891. https://doi.org/10.1007/s10067-016-3397-4
  • Haringman, J. J., Gerlag, D. M., Zwinderman, A. H., Smeets, T. J., Kraan, M. C., Baeten, D., McInnes, I. B., Bresnihan, B., & Tak, P. P. (2005, June). Synovial tissue macrophages: A sensitive biomarker for response to treatment in patients with rheumatoid arthritis. Annals of the Rheumatic Diseases, 64 (6), 834–838. https://doi.org/10.1136/ard.2004.029751
  • Haubruck, P., Pinto, M. M., Moradi, B., Little, C. B., & Gentek, R. (2021). Monocytes, macrophages, and their potential niches in synovial joints – Therapeutic targets in post-traumatic osteoarthritis? Frontiers in Immunology, 12, 763702. https://doi.org/10.3389/fimmu.2021.763702
  • Huang, Q. Q., Birkett, R., Doyle, R., Shi, B., Roberts, E. L., Mao, Q., & Pope, R. M. (2018, January). The role of macrophages in the response to TNF inhibition in experimental arthritis. Journal of Immunology, 200(1), 130–138. https://doi.org/10.4049/jimmunol.1700229
  • Humby, F., Lewis, M., Ramamoorthi, N., Hackney, J. A., Barnes, M. R., Bombardieri, M., Setiadi, A. F., Kelly, S., Bene, F., DiCicco, M., Riahi, S., Rocher, V., Ng, N., Lazarou, I., Hands, R., van der Heijde, D., Landewé, R. B. M., van der Helm van Mil, A., Alberto Cauli, A., ... Pitzalis, C. (2019, June). Synovial cellular and molecular signatures stratify clinical response to csDMARD therapy and predict radiographic progression in early rheumatoid arthritis patients. Annals of the Rheumatic Diseases, 78(6), 761–772. https://doi.org/10.1136/annrheumdis-2018-214539
  • Hunter, D. J., March, L., & Chew, M. (2020, November). Osteoarthritis in 2020 and beyond: A Lancet Commission. Lancet (London, England), 396(10264), 1711–1712. https://doi.org/10.1016/S0140-6736(20)32230-3
  • Karagiannidis, C., Akdis, M., Holopainen, P., Woolley, N. J., Hense, G., Rückert, B., Mantel, P.-Y., Menz, G., Akdis, C. A., Blaser, K., & Schmidt-Weber, C. B. (2004, December). Glucocorticoids upregulate FOXP3 expression and regulatory T cells in asthma. The Journal of Allergy and Clinical Immunology, 114(6), 1425–1433. https://doi.org/10.1016/j.jaci.2004.07.014
  • Kirsch, A. H., Mahmood, A. A., Endres, J., Bohra, L., Bonish, B., Weber, K., & Fox, D. A. (1999,). Apoptosis of human T-cells: Induction by glucocorticoids or surface receptor ligation in vitro and ex vivo. Journal of Biological Regulators and Homeostatic Agents, 13(2), 80–89.
  • Kivity, S., Zafrir, Y., Loebstein, R., Pauzner, R., Mouallem, M., & Mayan, H. (2014, November). Clinical characteristics and risk factors for low dose methotrexate toxicity: A cohort of 28 patients. Autoimmunity Reviews, 13(11), 1109–1113. https://doi.org/10.1016/j.autrev.2014.08.027
  • Krasselt, M., Gruz, N., Pierer, M., Baerwald, C., & Wagner, U. (2022, June 19). IL-10 induced by mTNF Crosslinking-Mediated reverse signaling in a whole blood assay is predictive of response to TNFi therapy in rheumatoid arthritis. Journal of Personalized Medicine, 12(6). https://doi.org/10.3390/jpm12061003
  • Kuo, D., Ding, J., Cohn, I. S., Zhang, F., Wei, K., Rao, D. A., Rozo, C., Sokhi, U. K., Shanaj, S., Oliver, D. J., Echeverria, A. P., DiCarlo, E. F., Brenner, M. B., Bykerk, V. P., Goodman, S. M., Raychaudhuri, S., Rätsch, G., Ivashkiv, L. B., & Donlin, L. T. (2019, May 8). HBEGF + macrophages in rheumatoid arthritis induce fibroblast invasiveness. Science Translational Medicine, 11(491). https://doi.org/10.1126/scitranslmed.aau8587
  • Kurowska-Stolarska, M., & Alivernini, S. (2022, July). Synovial tissue macrophages in joint homeostasis, rheumatoid arthritis and disease remission. Nature Reviews: Rheumatology, 18(7), 384–397. https://doi.org/10.1038/s41584-022-00790-8
  • Lalezari, J., Gathe, J., Brinson, C., Thompson, M., Cohen, C., Dejesus, E., Galindez, J., Ernst, J. A., Martin, D. E., & Palleja, S. M. (2011, June). Safety, efficacy, and pharmacokinetics of TBR-652, a CCR5/CCR2 antagonist, in HIV-1–infected, treatment-experienced, CCR5 antagonist–naive subjects. Journal of Acquired Immune Deficiency Syndromes (1999), 57(2), 118–125. https://doi.org/10.1097/QAI.0b013e318213c2c0
  • Liu, B., Dhanda, A., Hirani, S., Williams, E. L., Sen, H. N., Martinez Estrada, F., Ling, D., Thompson, I., Casady, M., Li, Z., Si, H., Tucker, W., Wei, L., Jawad, S., Sura, A., Dailey, J., Hannes, S., Chen, P., Chien, J. L., ... Nussenblatt, R. B. (2015, June). CD14++CD16+ monocytes are enriched by glucocorticoid treatment and are functionally attenuated in driving effector T cell responses. Journal of Immunology, 194(11), 5150–5160. https://doi.org/10.4049/jimmunol.1402409
  • Liu, W., Chen, Y., Zeng, G., Yang, S., Yang, T., Ma, M., & Song, W. (2021). Single-cell profiles of age-related osteoarthritis uncover underlying heterogeneity associated with disease progression. Frontiers in Molecular Biosciences, 8, 748360. https://doi.org/10.3389/fmolb.2021.748360
  • Longobardi, L., Jordan, J. M., Shi, X. A., Renner, J. B., Schwartz, T. A., Nelson, A. E., Barrow, D. A., Kraus, V. B., & Spagnoli, A. (2018, September). Associations between the chemokine biomarker CCL2 and knee osteoarthritis outcomes: The Johnston County osteoarthritis project. Osteoarthritis & Cartilage / OARS, Osteoarthritis Research Society, 26(9), 1257–1261. https://doi.org/10.1016/j.joca.2018.04.012
  • Lopez-Olivo, M. A., Siddhanamatha, H. R., Shea, B., Tugwell, P., Wells, G. A., & Suarez-Almazor, M. E. (2014, June). Methotrexate for treating rheumatoid arthritis. Cochrane Database of Systematic Reviews, 2014(6), CD000957. https://doi.org/10.1002/14651858.CD000957.pub2
  • Ma, W., Liu, C., Wang, S., Xu, H., Sun, H., & Fan, X. (2020, December). Efficacy and safety of intra-articular injection of mesenchymal stem cells in the treatment of knee osteoarthritis: A systematic review and meta-analysis. Medicine (Baltimore), 99(49), e23343. https://doi.org/10.1097/MD.0000000000023343
  • Makrygiannakis, D., Revu, S., Neregard, P., Af Klint, E., Snir, O., Grundtman, C., & Catrina, A. (2008). Monocytes are essential for inhibition of synovial T-cell glucocorticoid-mediated apoptosis in rheumatoid arthritis. Arthritis Research & Therapy, 10(6), R147. https://doi.org/10.1186/ar2582
  • Mancuso, P., Raman, S., Glynn, A., Barry, F., & Murphy, J. M. (2019). Mesenchymal stem cell therapy for osteoarthritis: The critical role of the cell secretome. Frontiers in Bioengineering and Biotechnology, 7, 9. https://doi.org/10.3389/fbioe.2019.00009
  • McAlindon, T. E., LaValley, M. P., Harvey, W. F., Price, L. L., Driban, J. B., Zhang, M., & Ward, R. J. (2017, May). Effect of intra-articular triamcinolone vs saline on knee cartilage volume and pain in patients with knee osteoarthritis: A randomized clinical trial. JAMA, 317(19), 1967–1975. https://doi.org/10.1001/jama.2017.5283
  • McGarry, T., Hanlon, M. M., Marzaioli, V., Cunningham, C. C., Krishna, V., Murray, K., Hurson, C., Gallagher, P., Nagpal, S., Veale, D. J., & Fearon, U. (2021). Rheumatoid arthritis CD14 + monocytes display metabolic and inflammatory dysfunction, a phenotype that precedes clinical manifestation of disease. Clinical & Translational Immunology, 10(1), e1237. https://doi.org/10.1002/cti2.1237
  • McInnes, I. B., Mease, P. J., Kirkham, B., Kavanaugh, A., Ritchlin, C. T., Rahman, P., van der Heijde, D., Landewé, R., Conaghan, P. G., Gottlieb, A. B., Richards, H., Pricop, L., Ligozio, G., Patekar, M., & Mpofu, S. (2015, September). Secukinumab, a human anti-interleukin-17A monoclonal antibody, in patients with psoriatic arthritis (FUTURE 2): A randomised, double-blind, placebo-controlled, phase 3 trial. Lancet (London, England), 386(9999), 1137–1146. https://doi.org/10.1016/S0140-6736(15)61134-5
  • McInnes, I. B., & Schett, G. (2007, June). Cytokines in the pathogenesis of rheumatoid arthritis. Nature Reviews: Immunology, 7(6), 429–442. https://doi.org/10.1038/nri2094
  • Meusch, U., Krasselt, M., Rossol, M., Baerwald, C., Klingner, M., & Wagner, U. (2015, August 7). In vitro response pattern of monocytes after tmTNF reverse signaling predicts response to anti-TNF therapy in rheumatoid arthritis. Journal of Translational Medicine, 13, 256. https://doi.org/10.1186/s12967-015-0620-z
  • Meusch, U., Rossol, M., Baerwald, C., Hauschildt, S., & Wagner, U. (2009, September). Outside-to-inside signaling through transmembrane tumor necrosis factor reverses pathologic interleukin-1β production and deficient apoptosis of rheumatoid arthritis monocytes. Arthritis & Rheumatism, 60(9), 2612–2621. https://doi.org/10.1002/art.24778
  • Moadab, F., Khorramdelazad, H., & Abbasifard, M. (2021, March 15). Role of CCL2/CCR2 axis in the immunopathogenesis of rheumatoid arthritis: Latest evidence and therapeutic approaches. Life Sciences, 269, 119034. https://doi.org/10.1016/j.lfs.2021.119034
  • Mondadori, C., Palombella, S., Salehi, S., Talò, G., Visone, R., Rasponi, M., Redaelli, A., Sansone, V., Moretti, M., & Lopa, S. (2021, July). Recapitulating monocyte extravasation to the synovium in an organotypic microfluidic model of the articular joint. Biofabrication, 13(4), 045001. https://doi.org/10.1088/1758-5090/ac0c5e
  • Mozo, L., Suarez, A., & Gutierrez, C. (2004, March). Glucocorticoids up-regulate constitutive interleukin-10 production by human monocytes. Clinical and Experimental Allergy: Journal of the British Society for Allergy and Clinical Immunology, 34(3), 406–412. https://doi.org/10.1111/j.1365-2222.2004.01824.x
  • Mulherin, D., Fitzgerald, O., & Bresnihan, B. (1996, January). Synovial tissue macrophage populations and articular damage in rheumatoid arthritis. Arthritis & Rheumatism, 39(1), 115–124. https://doi.org/10.1002/art.1780390116
  • Muller-Calleja, N., Manukyan, D., Canisius, A., Strand, D., & Lackner, K. J. (2017, May). Hydroxychloroquine inhibits proinflammatory signalling pathways by targeting endosomal NADPH oxidase. Annals of the Rheumatic Diseases, 76(5), 891–897. https://doi.org/10.1136/annrheumdis-2016-210012
  • Mushtaq, S., Choudhary, R., & Scanzello, C. R. (2011, September). Non-surgical treatment of osteoarthritis-related pain in the elderly. Current Reviews in Musculoskeletal Medicine, 4(3), 113–122. https://doi.org/10.1007/s12178-011-9084-9
  • Neumann, E., Riepl, B., Knedla, A., Lefèvre, S., Tarner, I. H., Grifka, J., Steinmeyer, J., Schölmerich, J., Gay, S., & Müller-Ladner, U. (2010). Cell culture and passaging alters gene expression pattern and proliferation rate in rheumatoid arthritis synovial fibroblasts. Arthritis Research & Therapy, 12(3), R83. https://doi.org/10.1186/ar3010
  • Paoletti, A., Rohmer, J., Ly, B., Pascaud, J., Rivière, E., Seror, R., Le Goff, B., Nocturne, G., & Mariette, X. (2019, October). Monocyte/macrophage abnormalities specific to rheumatoid arthritis are linked to miR-155 and are differentially modulated by different TNF inhibitors. Journal of Immunology, 203(7), 1766–1775. https://doi.org/10.4049/jimmunol.1900386
  • Ptacek, J., Hawtin, R. E., Sun, D., Louie, B., Evensen, E., Mittleman, B. B., Cesano, A., Cavet, G., Bingham III, C. O., Cofield, S. S., & Curtis, J. R. (2021). Diminished cytokine-induced Jak/STAT signaling is associated with rheumatoid arthritis and disease activity. PLoS One, 16(1), e0244187. https://doi.org/10.1371/journal.pone.0244187
  • Qian, T., Fujiwara, N., Koneru, B., Ono, A., Kubota, N., Jajoriya, A. K., Tung, M. G., Crouchet, E., Song, W.-M., Marquez, C. A., Panda, G., Hoshida, A., Raman, I., Li, Q.-Z., Lewis, C., Yopp, A., Rich, N. E., Singal, A. G., Nakagawa, S., ... Hoshida, Y. (2022, April). Molecular signature predictive of long-term liver fibrosis progression to inform antifibrotic drug development. Gastroenterology, 162(4), 1210–1225. https://doi.org/10.1053/j.gastro.2021.12.250
  • Quero, L., Hanser, E., Manigold, T., Tiaden, A. N., & Kyburz, D. (2017, November). TLR2 stimulation impairs anti-inflammatory activity of M2-like macrophages, generating a chimeric M1/M2 phenotype. Arthritis Research & Therapy, 19(1), 245. https://doi.org/10.1186/s13075-017-1447-1
  • Raghu, H., Lepus, C. M., Wang, Q., Wong, H. H., Lingampalli, N., Oliviero, F., Punzi, L., Giori, N. J., Goodman, S. B., Chu, C. R., Sokolove, J. B., & Robinson, W. H. (2017, May). CCL2/CCR2, but not CCL5/CCR5, mediates monocyte recruitment, inflammation and cartilage destruction in osteoarthritis. Annals of the Rheumatic Diseases, 76(5), 914–922. https://doi.org/10.1136/annrheumdis-2016-210426
  • Roberts, C. A., Dickinson, A. K., & Taams, L. S. (2015). The interplay between monocytes/macrophages and CD4(+) T cell subsets in rheumatoid arthritis. Frontiers in Immunology, 6, 571. https://doi.org/10.3389/fimmu.2015.00571
  • Sachsenweger, R. (1960). The variability of the apparent angle of strabismus. Albrecht von Graefe’s Archiv fur Ophthalmologie, 162, 166–177. https://doi.org/10.1007/BF00682419
  • Safi, W., Kuehnl, A., Nussler, A., Eckstein, H.-H., & Pelisek, J. (2016, April). Differentiation of human CD14+ monocytes: An experimental investigation of the optimal culture medium and evidence of a lack of differentiation along the endothelial line. Experimental & Molecular Medicine, 48(4), e227. https://doi.org/10.1038/emm.2016.11
  • Schmidt, T., Berthold, E., Arve-Butler, S., Gullstrand, B., Mossberg, A., Kahn, F., Bengtsson, A. A., Månsson, B., & Kahn, R. (2020, August). Children with oligoarticular juvenile idiopathic arthritis have skewed synovial monocyte polarization pattern with functional impairment—A distinct inflammatory pattern for oligoarticular juvenile arthritis. Arthritis Research & Therapy, 22(1), 186. https://doi.org/10.1186/s13075-020-02279-9
  • Schmidt, T., Dahlberg, A., Berthold, E., Król, P., Arve-Butler, S., Rydén, E., Najibi, S. M., Mossberg, A., Bengtsson, A. A., Kahn, F., Månsson, B., & Kahn, R. (2023). Synovial monocytes contribute to chronic inflammation in childhood-onset arthritis via IL-6/STAT signalling and cell-cell interactions. Frontiers in Immunology, 14, 1190018. https://doi.org/10.3389/fimmu.2023.1190018
  • Schumacher, H. R., & Chen, L. X. (2005, November). Injectable corticosteroids in treatment of arthritis of the knee. The American Journal of Medicine, 118(11), 1208–1214. https://doi.org/10.1016/j.amjmed.2005.05.003
  • Shahrara, S., Pickens, S. R., Dorfleutner, A., & Pope, R. M. (2009, March). IL-17 induces monocyte migration in rheumatoid arthritis. Journal of Immunology, 182(6), 3884–3891. https://doi.org/10.4049/jimmunol.0802246
  • Shipa, M. R. A., Amarnani, R., Yeoh, S. A., Mainuddin, M. D., & Ehrenstein, M. R. (2021, December). Early reduction in circulating monocyte count predicts maintenance of remission in patients with rheumatoid arthritis treated with anti-TNF therapy. Annals of the Rheumatic Diseases, 80(12), 1628–1629. https://doi.org/10.1136/annrheumdis-2021-220642
  • Smolen, J. S., Landewe, R., Bijlsma, J., Burmester, G., Chatzidionysiou, K., Dougados, M., Nam, J., Ramiro, S., Voshaar, M., van Vollenhoven, R., Aletaha, D., Aringer, M., Boers, M., Buckley, C. D., Buttgereit, F., Bykerk, V., Cardiel, M., Combe, B., Cutolo, M., ... van der Heijde, D. (2017, June). EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update. Annals of the Rheumatic Diseases, 76(6), 960–977. https://doi.org/10.1136/annrheumdis-2016-210715
  • Stankovic, A., Slavic, V., Stamenkovic, B., Kamenov, B., Bojanovic, M., & Mitrovic, D. R. (2009). Serum and synovial fluid concentrations of CCL2 (MCP-1) chemokine in patients suffering rheumatoid arthritis and osteoarthritis reflect disease activity. Bratislavske lekarske listy, 110(10), 641–646.
  • Tacke, F., & Randolph, G. J. (2006). Migratory fate and differentiation of blood monocyte subsets. Immunobiology, 211(6–8), 609–618. https://doi.org/10.1016/j.imbio.2006.05.025
  • Tak, P. P. (2012, April). A personalized medicine approach to biologic treatment of rheumatoid arthritis: A preliminary treatment algorithm. Rheumatology (Oxford), 51(4), 600–609. https://doi.org/10.1093/rheumatology/ker300
  • Tardito, S., Martinelli, G., Soldano, S., Paolino, S., Pacini, G., Patane, M., Alessandri, E., Smith, V., & Cutolo, M. (2019, November). Macrophage M1/M2 polarization and rheumatoid arthritis: A systematic review. Autoimmunity Reviews, 18(11), 102397. https://doi.org/10.1016/j.autrev.2019.102397
  • Taylor, P. C., Peters, A. M., Paleolog, E., Chapman, P. T., Elliott, M. J., McCloskey, R., Feldmann, M., & Maini, R. N. (2000, January). Reduction of chemokine levels and leukocyte traffic to joints by tumor necrosis factor α blockade in patients with rheumatoid arthritis. Arthritis & Rheumatism, 43(1), 38–47. https://doi.org/10.1002/1529-0131(200001)43:1<38:AID-ANR6>3.0.CO;2-L
  • Thomas, G., Tacke, R., Hedrick, C. C., & Hanna, R. N. (2015, June). Nonclassical patrolling monocyte function in the vasculature. Arteriosclerosis, Thrombosis, and Vascular Biology, 35(6), 1306–1316. https://doi.org/10.1161/ATVBAHA.114.304650
  • Thurlings, R. M., Vos, K., Wijbrandts, C. A., Zwinderman, A. H., Gerlag, D. M., & Tak, P. P. (2008, July). Synovial tissue response to rituximab: Mechanism of action and identification of biomarkers of response. Annals of the Rheumatic Diseases, 67(7), 917–925. https://doi.org/10.1136/ard.2007.080960
  • Toubi, E., Kessel, A., Slobodin, G., Boulman, N., Pavlotzky, E., Zisman, D., Rozenbaum, M., & Rosner, I. (2007, June). Changes in macrophage function after rituximab treatment in patients with rheumatoid arthritis. Annals of the Rheumatic Diseases, 66(6), 818–820. https://doi.org/10.1136/ard.2006.062505
  • Tsukamoto, M., Seta, N., Yoshimoto, K., Suzuki, K., Yamaoka, K., & Takeuchi, T. (2017, February). CD14(bright)CD16+ intermediate monocytes are induced by interleukin-10 and positively correlate with disease activity in rheumatoid arthritis. Arthritis Research & Therapy, 19(1), 28. https://doi.org/10.1186/s13075-016-1216-6
  • Tsukamoto, M., Suzuki, K., Seta, N., & Takeuchi, T. (2018,). Increased circulating CD14brightCD16+ intermediate monocytes are regulated by TNF-α and IL-6 axis in accordance with disease activity in patients with rheumatoid arthritis. Clinical and Experimental Rheumatology, 36(4), 540–544.
  • Tu, J., Hong, W., Zhang, P., Wang, X., Körner, H., & Wei, W. (2018). Ontology and function of fibroblast-like and macrophage-like synoviocytes: How do they talk to each other and can they be targeted for rheumatoid arthritis therapy? Frontiers in Immunology, 9, 1467. https://doi.org/10.3389/fimmu.2018.01467
  • Tucci, G., Garufi, C., Pacella, I., Zagaglioni, M., Pinzon Grimaldos, A., Ceccarelli, F., Conti, F., Spinelli, F. R., & Piconese, S. (2022). Baricitinib therapy response in rheumatoid arthritis patients associates to STAT1 phosphorylation in monocytes. Frontiers in Immunology, 13, 932240. https://doi.org/10.3389/fimmu.2022.932240
  • Uchiyama, R., Toyoda, E., Maehara, M., Wasai, S., Omura, H., Watanabe, M., & Sato, M. (2021, February 26). Effect of platelet-rich plasma on M1/M2 macrophage polarization. International Journal of Molecular Sciences, 22(5). https://doi.org/10.3390/ijms22052336.
  • Wang, Y., Yu, D., Liu, Z., Zhou, F., Dai, J., Wu, B., Zhou, J., Heng, B. C., Zou, X. H., Ouyang, H., & Liu, H. (2017, August). Exosomes from embryonic mesenchymal stem cells alleviate osteoarthritis through balancing synthesis and degradation of cartilage extracellular matrix. Stem Cell Research & Therapy, 8(1), 189. https://doi.org/10.1186/s13287-017-0632-0
  • Xue, J., Xu, L., Zhu, H., Bai, M., Li, X., Zhao, Z., Zhong, H., Cheng, G., Li, X., Hu, F., & Su, Y. (2020, September). CD14+CD16− Monocytes are the main precursors of osteoclasts in rheumatoid arthritis via expressing Tyro3TK. Arthritis Research & Therapy, 22(1), 221. https://doi.org/10.1186/s13075-020-02308-7
  • Yager, N., Cole, S., Lledo Lara, A., Maroof, A., Penkava, F., Knight, J. C., Bowness, P., & Al-Mossawi, H. (2021, December). Ex vivo mass cytometry analysis reveals a profound myeloid proinflammatory signature in psoriatic arthritis synovial fluid. Annals of the Rheumatic Diseases, 80(12), 1559–1567. https://doi.org/10.1136/annrheumdis-2021-220280
  • Yamaoka, K. (2016, June). Janus kinase inhibitors for rheumatoid arthritis. Current Opinion in Chemical Biology, 32, 29–33. https://doi.org/10.1016/j.cbpa.2016.03.006
  • Yarilina, A., Xu, K., Chan, C., & Ivashkiv, L. B. (2012, December). Regulation of inflammatory responses in tumor necrosis factor-activated and rheumatoid arthritis synovial macrophages by JAK inhibitors. Arthritis & Rheumatism, 64(12), 3856–3866. https://doi.org/10.1002/art.37691
  • Yoon, B. R., Yoo, S. J., Choi, Y., Chung, Y.-H., Kim, J., Yoo, I. S., Kang, S. W., & Lee, W.-W. (2014). Functional phenotype of synovial monocytes modulating inflammatory T-cell responses in rheumatoid arthritis (RA). PLoS One, 9(10), e109775. https://doi.org/10.1371/journal.pone.0109775
  • Zhang, B., Shan, H., Li, D., Li, Z.-R., Zhu, K.-S., Jiang, Z.-B., & Huang, M.-S. (2012, November). Different methods of detaching adherent cells significantly affect the detection of TRAIL receptors. Tumori Journal, 98(6), 800–803. https://doi.org/10.1177/030089161209800619
  • Zhang, F., Wei, K., Slowikowski, K., Fonseka, C. Y., Rao, D. A., Kelly, S., Goodman, S. M., Tabechian, D., Hughes, L. B., Salomon-Escoto, K., Watts, G. F. M., Jonsson, A. H., Rangel-Moreno, J., Meednu, N., Rozo, C., Apruzzese, W., Eisenhaure, T. M., Lieb, D. J., Boyle, D. L., ... Raychaudhuri, S. (2019, July). Defining inflammatory cell states in rheumatoid arthritis joint synovial tissues by integrating single-cell transcriptomics and mass cytometry. Nature Immunology, 20(7), 928–942. https://doi.org/10.1038/s41590-019-0378-1
  • Ziegler-Heitbrock, L. (2015). Blood monocytes and their subsets: Established features and open questions. Frontiers in Immunology, 6, 423. https://doi.org/10.3389/fimmu.2015.00423
  • Ziegler-Heitbrock, L., Ancuta, P., Crowe, S., Dalod, M., Grau, V., Hart, D. N., Leenen, P. J. M., Liu, Y.-J., MacPherson, G., Randolph, G. J., Scherberich, J., Schmitz, J., Shortman, K., Sozzani, S., Strobl, H., Zembala, M., Austyn, J. M., & Lutz, M. B. (2010, October). Nomenclature of monocytes and dendritic cells in blood. Blood, 116(16), e74–80. https://doi.org/10.1182/blood-2010-02-258558